Vistagen (VTGN) announced that the U.S. Patent and Trademark Office or USPTO, granted a patent to the company for its oral non-opioid product candidate, AV-101, for the treatment of neuropathic pain.

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

IPWatchdog has learned that Commissioner for Patents Vaishali Udupa has notified the United States Patent and Trademark Office (USPTO) that she is resigning effective immediately. Udupa has ...

Some teleworking patent examiners at the US Patent and Trademark Office have less than a week to return to agency offices in ...

Myriad Genetics, Inc., a leader in genetic and tumour genomic testing and precision medicine, announced that the United States Patent and Trademark Office (USPTO) issued two new patents that further ...

of the U.S. Patent and Trademark Office’s (USPTO’s) Patent Trial and Appeal Board (PTAB) will be asked to return to the office as soon as February 24—a move which former USPTO Director Kathi ...

Now, a newly published patent filed by Nintendo seems to confirm that feature and describes how it will work. The international patent was filed with the World Intellectual Property Organization ...

The patent showcases features like the ability to slide Joy-Cons on flat surfaces, offering a new way to interact with games. The Nintendo Switch 2 is expected to build on the success of its ...

Nicole Carpenter is a senior reporter specializing in investigative features about labor issues in the game industry, as well as the business and culture of games. Four Nintendo patents were made ...

And while Nintendo is staying stubbornly tightlipped until April, a newly surfaced patent appears to confirm at least a few previously reported details the company has so far only teased.